Sort
172,184 grants matching “inflammation”
CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE
$1,000,000University Of North Carolina Chapel Hill · P30 · FY2002 · DK
IND enabling development of LGM2605 as adjuvant treatment for asthma
$1,000,000Thais Motria Sielecki · Lignamed, Llc · R42 · FY2019 · AI
Human NeuromuscularJunction Platform to Evaluate Botulinum Toxin Potency
$1,000,000James F Kronauge · Hesperos, Llc · U44 · FY2024 · TR
Role of Inter-alpha Inhibitors in Anthrax Intoxication
$1,000,000Steven M. Opal · Prothera Biologics, Llc · R42 · FY2010 · AI
Clinical Development of a Therapeutic Agent for COPD
$1,000,000Indu Parikh · Biomarck Pharmaceuticals, Ltd · R44 · FY2013 · HL
Development of a dry powder inhalation product against Respiratory Syncytial Virus based on an endogenous anionic pulmonary surfactant lipid
$1,000,000Ajay Gupta · Celestial Therapeutics Inc. · R44 · FY2025 · AI
CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE
$1,000,000University Of North Carolina Chapel Hill · P30 · FY2004 · DK
CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE
$1,000,000University Of North Carolina Chapel Hill · P30 · FY2001 · DK
IND enabling development of LGM2605 as adjuvant treatment for asthma
$1,000,000Thais Motria Sielecki · Lignamed, Llc · R42 · FY2020 · AI
CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE
$1,000,000University Of North Carolina Chapel Hill · P30 · FY2003 · DK
Novel immunotherapy against MOG antibody disease
$1,000,000Weston Daniel · Evoq Therapeutics, Inc. · R44 · FY2024 · TR
Treatment of Inflammatory Complications of Respiratory Infection
$1,000,000Michael William Lark · Respana Therapeutics, Inc. · R42 · FY2024 · AI
Type 1 Diabetes triggers: diet modification in neonates
$1,000,000Diabetes Research Institute · U01 · FY2003 · DK
Antioxidant Mimetic as a Mitigator of Radiation Induced Lung Injury
$1,000,000Zeljko Vujaskovic · Duke University · RC1 · FY2010 · AI
CENTER FOR DIGESTIVE AND LIVER DISEASES
$1,000,000University Of Pennsylvania · P30 · FY2001 · DK
Clinical Development of a Therapeutic Agent for COPD
$1,000,000Indu Parikh · Biomarck Pharmaceuticals, Ltd · R44 · FY2014 · HL
Hepatoselective Dihydrozuinolizone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection
$1,000,000Yanming Du · Harlingene Life Sciences Llc · R42 · FY2025 · AI
Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool
$1,000,000Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2022 · AI
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis
$1,000,000Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2021 · HL
Generation of a temporal, spatial, and molecular map of in situ hematopoiesis
$1,000,000Fernando Camargo · Boston Children'S Hospital · RC2 · FY2022 · DK
Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool
$1,000,000Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2020 · AI
Simultaneous pharmacological profiling of oncogenic gene fusion proteins in cancer
$1,000,000Alexander Federation · Talus Bioscience, Inc. · R44 · FY2023 · CA
Human NeuromuscularJunction Platform to Evaluate Botulinum Toxin Potency
$1,000,000James F Kronauge · Hesperos, Llc · U44 · FY2025 · TR
Developing a Small Peptide to Control Autoimmune Inflammation In Type 1 Diabetes
$1,000,000David H Wagner · Op-T-Mune, Inc. · R42 · FY2019 · AI
Mount Sinai HHEAR Network Targeted Lab Hub
$1,000,000Robert O Wright · Icahn School Of Medicine At Mount Sinai · U2C · FY2020 · ES